Drs. Brian Nahed and Shannon Stott, together with a team comprised of biomedical engineers, cancer biologists, and clinicians, are working to develop the first blood based test for patients with brain tumors. Their recent success in capturing circulating tumor cells and exosomes in brain tumor patients serves as the catalyst for their combined effort to develop a comprehensive blood based tests for brain tumors. Nahed and Stott are currently enrolling patients into their translational research study at the MGH.

November 2, 2016 Comments Off on Research

Comments are closed.

« »